Spine Fusion clinical trials at UCSF
2 research studies open to eligible people
Ketamine on Intraoperative Motor Evoked Potentials
open to eligible people ages 18-100
The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.
San Francisco, California
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)
open to eligible people ages 10-21
The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.
San Francisco, California and other locations
Our lead scientists for Spine Fusion research studies include Marc Buren, MD Anshuman Sharma.
Last updated: